Axogen, Inc. — Director's Dealing 2021

Feb 10, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2021-02-05

Reporting Person: Donovan Michael Patrick (VP Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-05	Common Stock	M	20000	$5.14	Acquired	46029	Direct
2021-02-05	Common Stock	F	5190	$19.81	Disposed	40839	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-05	Employee Stock Option (right to purchase)	$5.14	M	20000	Disposed	2022-09-22	Common Stock (20000.0)	Direct

Footnotes

F1: All shares of Common Stock underlying the employee stock option became fully vested on September 22, 2019 (4 years from the option grant date).

F2: Represents the number of shares swapped to cover the exercise price of the options exercised via an attestation method stock swap in accordance with Rule16b-3.